Shibaguchi Hirotomo, Kuroki Masahide, Kuroki Motomu, Badran Adel, Hachimine Ken, Kinugasa Tetsushi
Department of Biochemistry, Fukuoka University School of Medicine, Fukuoka, 814-0180, Japan.
Anticancer Res. 2004 Sep-Oct;24(5C):3355-60.
Taking into consideration immunogenicity in humans, human antibodies and their derivatives have potential advantages for cancer immunotherapy and/or gene therapy over those from different species such as mouse. Recently, we generated 22 human monoclonal antibodies (HmAbs) specific for human carcinoembryonic antigen (CEA) using KM mouse, which carries human antibody genes. In the present study, we tried to clone the variable (V) region genes of the C2-45 HmAb, with the highest affinity for CEA and to generate a human single-chain variable fragmented (scFv) antibody.
Using RT-PCR methods, we cloned and sequenced cDNAs encoding V regions of C2-45, and constructed an scFv gene including a signal sequence for secreting into the periplasmic space of E. coli.
Soluble scFv antibody, designated 45KHscFv, was secreted in the periplasmic space and purified by Ni2+ affinity column from the supernatant of E. coli after osmotic shock. When analyzed by SDS-PAGE, the 45KHscFv antibody showed a band corresponding to a calculated molecular weight of 30 kDa. The 45KHscFv antibody also retained a high reactivity with CEA in ELISA using immobilized CEA.
These results indicate that the nonimmunogenic 45KHscFv antibody could be advantageously used for fusing with other human functional proteins such as cytokines.
考虑到在人体中的免疫原性,与来自不同物种(如小鼠)的抗体相比,人源抗体及其衍生物在癌症免疫治疗和/或基因治疗方面具有潜在优势。最近,我们利用携带人抗体基因的KM小鼠,制备了22种针对人癌胚抗原(CEA)的人单克隆抗体(HmAbs)。在本研究中,我们试图克隆对CEA具有最高亲和力的C2-45 HmAb的可变(V)区基因,并制备人单链可变片段(scFv)抗体。
采用RT-PCR方法,我们克隆并测序了编码C2-45 V区的cDNA,并构建了一个scFv基因,该基因包含一个用于分泌到大肠杆菌周质空间的信号序列。
可溶性scFv抗体,命名为45KHscFv,分泌到周质空间,并通过渗透压休克后从大肠杆菌上清液中用Ni2+亲和柱纯化。通过SDS-PAGE分析,45KHscFv抗体显示出一条对应于计算分子量30 kDa的条带。在使用固定化CEA的ELISA中,45KHscFv抗体也与CEA保持高反应性。
这些结果表明,非免疫原性的45KHscFv抗体可有利地用于与其他人类功能蛋白(如细胞因子)融合。